Recent surge in pharma patent litigation
The next decade or so in the pharmaceutical patent space in India will be interesting to watch out for. As more product patents…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis India reports loss for the quarter ended 31 December 2014
During the quarter under review, profit before tax was Rs 4.4 crore as against Rs 21.6 crore in the previous corresponding period…
Biotech Special
The last few years have been painful for India’s biotech sector but many companies have turned adversity into opportunity. Express…
Panacea Biotec: A Turnaround Story
After three consecutive years of negative EBITDA, Panacea Biotec looks set to script a successful revival. Dr Rajesh Jain, Joint…
Fermenta Biotech Limited: Tough gets going
Since the past few years, lack of funding, distrustful investors, and weak global economic conditions have made survival a tall…
Evolva Biotech: Evolving Spirit
Providing innovative, high value, sustainable ingredients, in particular for the health, wellness and nutrition segment, Evolva…
‘I expect a number of IPOs in India and capital inflow for novel ideas’
The 15th edition of Bangalore INDIA BIO 2015 will focus on showcasing to the world the strides taken by Indian companies in the…
Lupin receives FDA nod for generic vancocin capsules
Vancocin capsules had annual US sales of $ 164.2 million.
US FDA expands uses of Vyvanse to treat binge-eating disorder
The drug is the first FDA-approved medication to treat this condition
International conference on regulatory in emerging markets
Date: April 9-10, 2015
Venue: Hotel Westin, Mumbai